Bronte Capital Management Pty Ltd. Q4 2020 Filing
Filed February 3, 2021
Portfolio Value
$632.9B
Holdings
15
Report Date
Q4 2020
Filing Type
13F-HR
All Holdings (15 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | BRK/BBERKSHIRE HATHAWAY INC DEL | 491,444 | $114.0B | 18.00% | |
| 2 | HLFHERBALIFE NUTRITION LTD | 2,061,245 | $99.0B | 15.65% | |
| 3 | IBKRINTERACTIVE BROKERS GROUP | 1,289,241 | $78.5B | 12.41% | |
| 4 | VVISA INC | 312,438 | $68.3B | 10.80% | |
| 5 | IWMISHARES TR | 30,000 | $59.2B | 9.36% | Call |
| 6 | SPYSPDR S&P 500 ETF TR | 15,000 | $56.3B | 8.90% | Call |
| 7 | CTVACORTEVA NC | 835,714 | $32.4B | 5.11% | |
| 8 | GOOGALPHABET INC | 14,490 | $23.5B | 3.71% | |
| 9 | GOOGLALPHABET INC | 12,586 | $22.0B | 3.48% | |
| 10 | BKBANK NEW YORK MELLON CORP | 480,315 | $20.4B | 3.22% | |
| 11 | NEMNEWMONT CORP | 331,769 | $19.9B | 3.14% | |
| 12 | STTSTATE STR CORP | 263,537 | $19.2B | 3.03% | |
| 13 | REGNREGENERON PHARMACEUTICALS | 19,053 | $9.2B | 1.45% | |
| 14 | GHCGRAHAM HLDGS CO | 13,588 | $7.2B | 1.15% | |
| 15 | MACKEURMERRIMACK PHARMACEUTICALS IN | 531,510 | $3.7B | 0.58% |